Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension / 中华男科学杂志
National Journal of Andrology
; (12): 830-834, 2007.
Article
em Zh
| WPRIM
| ID: wpr-232052
Biblioteca responsável:
WPRO
ABSTRACT
The epidemiological survey shows that primary hypertension is one of the independent risk factors in the development and the progress of BPH, 25 percent of old male patients aged 60 or more suffer from the two diseases at the same time, which grievously affects their quality of life. There is little literature about the appropriate therapeutic regimen of BPH associated hypertension. The article reviews the progress in the studies of alpha1-adrenoceptor blocker for BPH associated hypertension, and explores the main problems facing us and ventures the prospects for the development in this field.
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Hiperplasia Prostática
/
Prazosina
/
Antagonistas Adrenérgicos alfa
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Antagonistas de Receptores Adrenérgicos alfa 1
/
Hipertensão
Limite:
Aged
/
Aged80
/
Humans
/
Male
Idioma:
Zh
Revista:
National Journal of Andrology
Ano de publicação:
2007
Tipo de documento:
Article